These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12142387)

  • 1. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach toward development of a rapid blood test for breast cancer.
    Vlahou A; Laronga C; Wilson L; Gregory B; Fournier K; McGaughey D; Perry RR; Wright GL; Semmes OJ
    Clin Breast Cancer; 2003 Aug; 4(3):203-9. PubMed ID: 14499014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
    Soltys SG; Le QT; Shi G; Tibshirani R; Giaccia AJ; Koong AC
    Clin Cancer Res; 2004 Jul; 10(14):4806-12. PubMed ID: 15269156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
    Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
    J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
    Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
    Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
    Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
    Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteome analysis for identification of tumor-associated biomarkers in breast cancer].
    Wang X; Liang WJ; Zhu ZY; Yang MT; Zeng YX
    Ai Zheng; 2004 Nov; 23(11 Suppl):1577-81. PubMed ID: 15566683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].
    Hu Y; Zhang SZ; Yu JK; Liu J; Zheng S; Hu X
    Ai Zheng; 2005 Jan; 24(1):67-71. PubMed ID: 15642203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly sensitive detection of melanoma based on serum proteomic profiling.
    Caron J; Mangé A; Guillot B; Solassol J
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1257-64. PubMed ID: 19288131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix.
    Wong YF; Cheung TH; Lo KW; Wang VW; Chan CS; Ng TB; Chung TK; Mok SC
    Cancer Lett; 2004 Aug; 211(2):227-34. PubMed ID: 15219946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.
    Hu Y; Zhang S; Yu J; Liu J; Zheng S
    Breast; 2005 Aug; 14(4):250-5. PubMed ID: 16085230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.
    Becker S; Cazares LH; Watson P; Lynch H; Semmes OJ; Drake RR; Laronga C
    Ann Surg Oncol; 2004 Oct; 11(10):907-14. PubMed ID: 15383419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
    Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
    Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.